Literature DB >> 22124953

Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient.

L Ceccarelli, G Calisti, D Delle Rose, A Ricciardi, G Maffongelli, P Sordillo, L Sarmati, M Andreoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22124953     DOI： 10.1007/s15010-011-0225-2

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   7.455


× No keyword cloud information.
  10 in total

Review 1.  Infections due to Pseudallescheria/Scedosporium species in patients with advanced HIV disease--a diagnostic and therapeutic challenge.

Authors:  Ina Tammer; Kathrin Tintelnot; Rüdiger C Braun-Dullaeus; Christian Mawrin; Cordula Scherlach; Dirk Schlüter; Wolfgang König
Journal:  Int J Infect Dis       Date:  2011-04-20       Impact factor: 3.623

2.  Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner.

Authors:  T Suda; Y Suzuki; T Matsui; T Inoue; O Niide; T Yoshimaru; H Suzuki; C Ra; T Ochiai
Journal:  Br J Dermatol       Date:  2005-05       Impact factor: 9.302

3.  Dapsone-induced infectious mononucleosis-like syndrome in a patient with pemphigus vulgaris.

Authors:  Jian-Guang Zhou; Sui-Qing Cai; Min Zheng
Journal:  Chin Med J (Engl)       Date:  2007-06-20       Impact factor: 2.628

Review 4.  Scedosporium apiospermum infection after near-drowning.

Authors:  Aspasia Katragkou; John Dotis; Maria Kotsiou; Maria Tamiolaki; Emmanuel Roilides
Journal:  Mycoses       Date:  2007-09       Impact factor: 4.377

Review 5.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

6.  In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.

Authors:  Joseph Meletiadis; Johan W Mouton; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

Review 7.  Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases.

Authors:  Juan Luis Rodriguez-Tudela; Juan Berenguer; Josep Guarro; A Serda Kantarcioglu; Regine Horre; G Sybren de Hoog; Manuel Cuenca-Estrella
Journal:  Med Mycol       Date:  2009-06       Impact factor: 4.076

8.  Fatal pulmonary scedosporiosis.

Authors:  R Horré; B Jovanić; G Marklein; G Schumacher; N Friedrichs; T Neuhaus; G S de Hoog; W H J Becker; S M Choi; K P Schaal
Journal:  Mycoses       Date:  2003       Impact factor: 4.377

9.  Dapsone-induced agranulocytosis leading to perianal abscess and death: a case report.

Authors:  Yoshiro Kobe; Daisuke Setoguchi; Nobuya Kitamura
Journal:  J Med Case Rep       Date:  2011-03-16

10.  The Dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations.

Authors:  Semaan G Kosseifi; Bhuvana Guha; Dima N Nassour; David S Chi; Guha Krishnaswamy
Journal:  J Occup Med Toxicol       Date:  2006-06-06       Impact factor: 2.646
  10 in total
  2 in total

Review 1.  Pulmonary scedosporiosis mimicking aspergilloma in an immunocompetent host: a case report and review of the literature.

Authors:  Fasih Ur Rahman; Muhammad Irfan; Naima Fasih; Kauser Jabeen; Hasanat Sharif
Journal:  Infection       Date:  2015-09-09       Impact factor: 3.553

2.  Scedosporium spp lung infection in immunocompetent patients: A systematic review and MOOSE-compliant meta-analysis.

Authors:  Wei Liu; Rui-Zhi Feng; Hong-Li Jiang
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.